Ultralife Corporation (ULBI)
After hours:
| Previous close | 4.0000 |
| Open | 3.9700 |
| Bid | 3.9600 x 900 |
| Ask | 4.0000 x 1400 |
| Day's range | 3.9600 - 4.0800 |
| 52-week range | 3.6700 - 5.7800 |
| Volume | |
| Avg. volume | 33,427 |
| Market cap | 64.381M |
| Beta (5Y monthly) | 1.18 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.0670 |
| Earnings date | 01 Feb 2023 - 06 Feb 2023 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Simply Wall St.
Bullish insiders bet US$1.6m on Ultralife Corporation (NASDAQ:ULBI)
Usually, when one insider buys stock, it might not be a monumental event. But when multiple insiders are buying like...
- GlobeNewswire
Ultralife Corporation Names Michael E. Manna President & CEO
NEWARK, N.Y., Nov. 22, 2022 (GLOBE NEWSWIRE) -- The Board of Directors of Ultralife Corporation (“Ultralife” or the “Company”) (NASDAQ: ULBI) has appointed Michael E. Manna as the Company’s President & CEO and as a member of the Board of Directors effective immediately to replace Michael D. Popielec who is leaving the Company. Mr. Popielec will remain with Ultralife as an employee for a sixty-day period ending January 20, 2023 in an advisory role to ensure a smooth leadership transition. In addi
- GlobeNewswire
Ultralife Corporation Reports Third Quarter Results
NEWARK, N.Y., Oct. 27, 2022 (GLOBE NEWSWIRE) -- Ultralife Corporation (NASDAQ: ULBI) reported an operating loss of $0.6 million and adjusted EBITDA of $1.3 million on revenue of $33.2 million for the third quarter ended September 30, 2022. For the third quarter of 2021, the Company reported an operating loss of $0.8 million and adjusted EBITDA of $0.3 million on revenue of $21.8 million. “For the third quarter, government/defense revenue doubled year-over-year reflecting higher demand from our c
